Book a demo

Company intelligence

Octapharma Germany

Passion for new health solutions advancing human life

Pharmaceutical Manufacturing
Springe, DE
127 employees
Founded 1983
1 public signals

About Octapharma Germany

Octapharma is the world's largest privately-owned, independent company specializing in the field of blood plasma fractionation. With over 11,000 employees, we lead in the development and production of essential human proteins derived from human plasma and human cell lines. We support the treatment of patients in 118 countries with products across three therapeutic areas: Immunotherapy, Hematology, and Critical Care. Octapharma has seven R&D sites and five state-of-the-art manufacturing facilities in Austria, France, Germany and Sweden, and operates more than 190 plasma donation centers across Europe and the US. Out sites in Germany: šŸ“ Octapharma Produktionsgesellschaft Deutschland mbH, Springe šŸ“ Octapharma Dessau GmbH, Dessau šŸ“ Octapharma Biopharmaceuticals GmbH, Heidelberg, Frankfurt, Berlin šŸ“ Octapharma GmbH, Langenfeld šŸ“ Octapharma Plasma GmbH, Langenfeld Community guidelines: https://bit.ly/3M8ioml

Verified activity

Signals from Octapharma Germany

1 published signal

Find the companies already in motion.

Customize signals around your market, buyers, competitors, and investment thesis.

Ā© 2026 SeedOpsCompany intelligence.

SeedOps.

Octapharma Germany Company Signals | SeedOps